Strengthen Infection Prevention and Control Regulations and Antibiotic Surveillance through Post-Acute Analytics

November 2, 2022 | Written by: Cheryl Scalzo, RN, Clinical Account Specialist

As CMS continues to enforce the regulatory process around infection prevention and control (IPC) efforts, there is an increased focus on the Long-Term Care Phase 3 Requirements of Participation (RoP). With ongoing efforts to address COVID-19, the spotlight remains on IPC and specifically, on the role of the Infection Preventionist (IP) and Antibiotic Stewardship.

Approximately 40-75% of prescribed antibiotics in skilled nursing facilities (SNF) may be unwarranted or unsuitable, resulting in serious risk of infections, increased adverse drug interactions and events, and even death. There is also the serious threat of antibiotic-resistant infections, which afflict 2.8 million Americans annually.

With regulations and IPC focused surveys imminent for care providers, and hospitalizations that have arisen because of facility acquired infections, it is imperative to be proactive in managing IPC. Therefore, the question remains– how do post-acute providers improve antibiotic utilization while reducing antibiotic resistance within their facilities


Challenges Post-Acute Care Providers Face in Managing Infection Control 

According to the CDC, between 1 and 3 million serious infections occur in nursing facilities annually. As many post-acute providers continue to grapple with staffing challenges and meeting regulatory requirements, identifying the specific infection control barriers they face is important to prevention efforts.

Undoubtedly, the staffing crisis is a challenge for everyone, and many nurses are wearing multiple hats filling several roles. With Phase 3 RoP resuming and CMS requiring that every facility have a dedicated part-time IP (at a minimum), the push for IPC efforts is becoming more prevalent than ever before. However, care providers face numerous challenges in implementing these types of efforts including surveillance, tracking, and trending of infectious diseases and outbreaks. Additionally, implementing improvement interventions and developing educational resources continue to be challenging for facilities. All of these tasks are extremely time consuming and very laborious, leading to more work for care providers, with less resources. Nonetheless, the IPC programs still need to be kept a priority.


Implementing Infection Prevention and Control Programs for Better Patient Outcomes

Monitoring and tracking infections and antibiotic usage can be an arduous and lengthy process, but essential in improving outcomes and eliminating potential infectious outbreaks, and adverse effects of antibiotic usage. The right technology can help to identify early warning signs of infections such as: C- difficile, Pneumonia, COVID-19, etc., and highlight the need for possible testing to determine the appropriate drug interventions.

CMS’ Infection Prevention Control Program (IPCP) encompass a system for preventing, identifying, reporting, investigating, and controlling infections and communicable diseases. Furthermore, recording incidents identified under the IPCP, and corrective actions taken by the facility will also be mandated within the program. By pairing strategy with technology, care providers can improve antibiotic usage and operationalize through the requirements and policies. This will strengthen IPC programs, reduce antibiotic resistance, and minimize unnecessary adverse drug events. Post-acute facilities can also leverage live data analysis to meet state and federal requirements, prepare for regulatory reporting and onsite surveys, and conduct infection surveillance.


Intervening in Care to Help Stop the Spread of Infection 

To date, there are approximately 15,600 CMS certified nursing homes in the United States, with 6-10% of those populations receiving antibiotics on any given day. Furthermore, 50-70% of post-acute patients will receive one or more antibiotic courses in a year. This year, it is expected to be a more active flu season than in the past two years. Along with Influenza, there is still variants of COVID-19, RSV, pneumonia, C-difficile, UTI, etc. present, and prevention and control must be the focus.

Technological solutions can assist with early identification or onsets of infectious processes, and detection of potential outbreaks. Additionally, having the right solution for automation of tracking and trending is a huge benefit in saving time and interceding early. Thus, allowing for earlier intervention and prevention in the spread of infection. By unlocking the data within the EHR, data analytics can be extremely useful to seamlessly find ways to automate processes (surveillance, tracking, trending, and mapping), as well as meeting many of the antibiotic stewardship requirements.

Through Real Time Medical Systems (Real Time) solution, data analysis is available to support and compliment IPC and antibiotic stewardship efforts. With Real Time’s Interventional Analytics, surveillance is easily populated and displayed. By simplifying the data analyzation and corrective interventions, competency-based training can be done when and where it is needed. Timely identification of signs and symptoms of infections, and new orders for antibiotics allows IP to manage accordingly. This can be achieved by tracking, establishing benchmarks, sharing data, etc. and offer prescribing profiles to care providers. By doing this, post-acute facilities can better manage IPC efforts, ultimately leading to improved patient outcomes.

To learn more about the ways Real Time can help, contact us today.

Insights Delivered

Get our latest news in your inbox.
  • This field is for validation purposes and should be left unchanged.

Our Partners